Novartis Commits $100M to Startup With Tech That Brings Peptides to Undruggable Targets
Novartis is looking to build up its cardiovascular drug pipeline and it’s now partnering with Unnatural Products to…
Novartis, UNP, Launch Up-to-$1.8B+ Macrocyclic Peptide Partnership
Novartis will apply Unnatural Products (UNP)’s artificial intelligence (AI)-guided macrocyclic peptide platform to develop next-generation cardiovascular disease therapeutics,…